revakinagene taroretcel-lwey
revakinagene taroretcel-lwey is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including ENCELTO. Available dosage form: implant.
Drug Details
- Generic Name
- revakinagene taroretcel-lwey
- Brand Names
- ENCELTO
- Application Number
- BLA125798
- Sponsor
- Neurotech Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- IMPLANT
- Routes
- INTRAVITREAL
- Active Ingredients
- REVAKINAGENE TARORETCEL
Indications and Usage
1 INDICATIONS AND USAGE ENCELTO is indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel). ENCELTO is an allogeneic encapsulated cell-based gene therapy indicated for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel).